Study of Spino-pelvic Sagittal Balance by Vicon® Optoelectronic System (VICON-SPINE)

June 26, 2020 updated by: University Hospital, Rouen

Study of Spino-pelvic Sagittal Balance by Vicon® Optoelectronic System - Model of Non-invasive Kyphosis

Spinal diseases often induce gait disorders with multifactorial origins such as lumbar pain, radicular pain, neurologic complications, or spinal deformities. However, radiography does not permit an analysis of spinal dynamics; therefore, sagittal balance dynamics during gait remain largely unexplored. This prospective and controlled study try to assess the Vicon system for detecting sagittal spinopelvic imbalance and to determine the modification induced by ant induced anterior sagittal imbalance on the kinetics walking parameters

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France
        • Rouen university hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male subjects
  • Aged between 20 to 40 years
  • Height between 165 to 190 centimeters
  • Asymptomatic subjects from spinal point of view
  • BMI < 30 kg/m²
  • Affiliated to French Social Security
  • Subjects having read the information note and signed informed consent

Exclusion Criteria:

  • Subjects with neurological, vestibular, rheumatological or orthopedic pathology which can influence walking and balance
  • Subjects with known spinal pathology
  • Subjects with visible morphologic spinal deformity
  • Subjects with significant visual impairment (visual acuity < 6/10) despite an optical correction port
  • Subjects unable to walk without help
  • Person placed under the safeguard of justice, guardianship or curatorship
  • Subjects involved in other biomedical research during this study
  • Subjects presenting an asymptomatic spinal pathology discovered at the inclusion on the spinal EOS images.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: healthy volunteers
EOS X-rays is done with et without a kyphosis induced corset and 8-meters walk test measured by optoelectronic Vicon system with et without a kyphosis induced corset
EOS X-rays is done with et without a kyphosis induced corset
8-meters walk test measured by optoelectronic Vicon system with et without a kyphosis induced corset

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variations in spino-pelvic sagittal balance measured by EOS X-ray
Time Frame: 1 hour
Variations in spino-pelvic sagittal balances measured with et without a kyphosis induced corset measured by the GSC7 on EOS X-rays and by the C7-T10-Sacrum angle on optoelectronic Vicon system.
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Position of the ground point projection of the center of mass
Time Frame: 1 hour
Position of the ground point projection of the center of mass with and without corset
1 hour
vertical deceleration of the center of mass during the second part of the oscillating phase
Time Frame: 1 hour
vertical deceleration of the center of mass during the second part of the oscillating phase with and without corset.
1 hour
Velocity of the center of mass during the second part of the oscillating phase
Time Frame: 1 hour
Velocity of the center of mass during the second part of the oscillating phase with and without corset.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mourad OULD SLIMANE, MD, Rouen university hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 17, 2018

Primary Completion (ACTUAL)

January 16, 2020

Study Completion (ACTUAL)

January 16, 2020

Study Registration Dates

First Submitted

April 26, 2018

First Submitted That Met QC Criteria

May 14, 2018

First Posted (ACTUAL)

May 24, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 29, 2020

Last Update Submitted That Met QC Criteria

June 26, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/066/HP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kyphosis

Clinical Trials on EOS X-rays

3
Subscribe